![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Factors Associated With HBV Response to B/F/TAF
Versus DTG + F/TDF at Week 96 in People With HIV-1 and HBV
|
|
|
CROI 2024 March 3-6 Denver
Anchalee Avihingsanon1, Hongzhou Lu2, Chee Loon Leong3, Chien-Ching Hung4, Sasisopin Kiertiburanakul5, Man-Po Lee6, Khuanchai Supparatpinyo7, Fujie Zhang8, Jason T Hindman9, Hongyuan Wang9, Hui Liu9, Taisheng Li
1HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand; 2Shanghai Public Health Clinical Center, Shanghai, China; 3Kuala Lumpur General Hospital, Kuala Lumpur, Malaysia; 4National Taiwan University Hospital, Yunlin, Taiwan; 5Faculty of Medicine, Ramathibodi Hospital, Bangkok, Thailand;
6Queen Elizabeth Hospital, Kowloon, Hong Kong; 7Chiang Mai University, Chiang Mai, Thailand; 8Beijing Ditan Hospital, Beijing, China; 9Gilead Sciences, Inc., Foster City, CA, USA; 10Peking Union Medical College Hospital, Beijing, China
![0314241](../images/031524/031524-6/0314241.gif)
![0314242](../images/031524/031524-6/0314242.gif)
![0314243](../images/031524/031524-6/0314243.gif)
![0314244](../images/031524/031524-6/0314244.gif)
![0314245](../images/031524/031524-6/0314245.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|